ARVINAS, INC. Income Tax Expense
ARVINAS, INC. (ARVN) reported Income Tax Expense of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-04
- ARVINAS, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $200.00K.
- ARVINAS, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $100.00K, a 50.00% decline year-over-year.
- ARVINAS, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $200.00K.
- ARVINAS, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was $300.00K, a 50.00% decline year-over-year.
- ARVINAS, INC. income tax expense (benefit) for fiscal 2025 was $300.00K, a 50.00% decline from fiscal 2024.
- ARVINAS, INC. income tax expense (benefit) for fiscal 2024 was $600.00K, a 33.33% decline from fiscal 2023.
- ARVINAS, INC. income tax expense (benefit) for fiscal 2023 was $900.00K, a 95.69% decline from fiscal 2022.
- ARVINAS, INC. income tax expense (benefit) for fiscal 2022 was $20.90M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-04 | $300.00K 10-Q · filed 2026-08-04 | $500.00K derived: sum of 3 quarters · filed 2026-08-04 | $800.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-11 | $300.00K derived: sum of 2 quarters · filed 2026-05-11 | $600.00K derived: sum of 3 quarters · filed 2026-05-11 | $300.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $500.00K derived: sum of 2 quarters · filed 2026-02-24 | $200.00K derived: sum of 3 quarters · filed 2026-08-04 | $300.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $100.00K 10-Q · filed 2025-11-05 | -$200.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$300.00K 10-Q · filed 2026-08-04 | -$200.00K 10-Q · filed 2026-08-04 | -$500.00K derived: sum of 3 quarters · filed 2026-08-04 | $100.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $200.00K 10-Q · filed 2026-05-11 | -$200.00K derived: sum of 2 quarters · filed 2026-05-11 | $400.00K derived: sum of 3 quarters · filed 2026-05-11 | $600.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $200.00K derived: sum of 2 quarters · filed 2026-02-24 | $400.00K derived: sum of 3 quarters · filed 2026-02-24 | $600.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $600.00K 10-Q · filed 2025-11-05 | $800.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.00M 10-Q · filed 2025-11-05 | $2.50M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-06 | $300.00K 10-Q · filed 2025-08-06 | $1.90M derived: sum of 3 quarters · filed 2026-02-24 | $1.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-01 | $1.70M derived: sum of 2 quarters · filed 2026-02-24 | $1.70M derived: sum of 3 quarters · filed 2026-02-24 | $1.40M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.60M derived: sum of 2 quarters · filed 2026-02-24 | $1.30M derived: sum of 3 quarters · filed 2026-02-24 | $900.00K 10-K · filed 2026-02-24 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-30 | -$300.00K derived: sum of 2 quarters · filed 2024-10-30 | -$700.00K 10-Q · filed 2024-10-30 | $10.10M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$300.00K 10-Q · filed 2024-07-30 | -$700.00K 10-Q · filed 2024-07-30 | $10.10M derived: sum of 3 quarters · filed 2025-02-11 | $12.30M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | -$400.00K 10-Q · filed 2024-05-07 | $10.40M derived: sum of 2 quarters · filed 2025-02-11 | $12.60M derived: sum of 3 quarters · filed 2025-02-11 | $16.00M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $13.00M derived: sum of 2 quarters · filed 2025-02-11 | $16.40M derived: sum of 3 quarters · filed 2025-02-11 | $20.90M 10-K · filed 2025-02-11 |
| 2022-09-30 | $2.20M 10-Q · filed 2023-11-07 | $5.60M derived: sum of 2 quarters · filed 2023-11-07 | $10.10M 10-Q · filed 2023-11-07 | $10.10M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $3.40M 10-Q · filed 2023-08-08 | $7.90M 10-Q · filed 2023-08-08 | $7.90M derived: sum of 3 quarters · filed 2024-02-27 | $7.90M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $4.50M 10-Q · filed 2023-05-05 | $4.50M derived: sum of 2 quarters · filed 2024-02-27 | $4.50M derived: sum of 3 quarters · filed 2024-02-27 | $4.50M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | $0.00 10-K · filed 2020-03-16 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $0.00 derived: sum of 2 quarters · filed 2019-03-26 | $0.00 10-K · filed 2019-03-26 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |